Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive Giovanni Caforio as its ...

Weak, peeling nails? Meet the nail serum that reforms biters and gel addicts - and keeps selling out Elizabeth Hurley opens up on her experience using £5,000 skincare device and reveals why it's worth ...